Schedule of Percentage of Consolidated Revenues Attributable to Geographical Locations (Details) - Revenue Benchmark [Member] - Product Concentration Risk [Member]	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Product Information [Line Items]
Total	100.00%	100.00%	100.00%	100.00%
UNITED STATES
Product Information [Line Items]
Total	42.00%	76.00%	54.00%	74.00%
Outside United States Pharma Services [Member]
Product Information [Line Items]
Total	57.00%	24.00%	41.00%	26.00%
United States Laboratory Developed Test Services [Member]
Product Information [Line Items]
Total	1.00%	0.00%	4.00%	0.00%